• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Oxazepines 1,4-oxazepines

Research Brief on Ethyl 4-Boc-2-homomorpholinecarboxylate (CAS: 1363166-21-5): Recent Advances and Applications

Ethyl 4-Boc-2-homomorpholinecarboxylate (CAS: 1363166-21-5) is a key intermediate in the synthesis of various bioactive compounds, particularly in the field of medicinal chemistry. Recent studies have highlighted its significance in the development of novel therapeutic agents, owing to its unique structural properties and versatility in chemical transformations. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, applications, and potential in drug discovery.

One of the most notable advancements in the use of Ethyl 4-Boc-2-homomorpholinecarboxylate is its role in the synthesis of morpholine derivatives, which are widely recognized for their pharmacological activities. Recent publications have demonstrated its efficacy as a building block in the construction of complex molecules, particularly those targeting central nervous system (CNS) disorders. Researchers have successfully utilized this compound to develop potent inhibitors of enzymes involved in neurodegenerative diseases, such as Alzheimer's and Parkinson's.

In addition to its applications in CNS drug development, Ethyl 4-Boc-2-homomorpholinecarboxylate has also been employed in the synthesis of anticancer agents. A 2023 study published in the Journal of Medicinal Chemistry reported the use of this compound in the design of small-molecule inhibitors targeting specific oncogenic pathways. The study highlighted the compound's ability to enhance the bioavailability and metabolic stability of the resulting drug candidates, making it a valuable tool in oncology research.

From a synthetic chemistry perspective, recent efforts have focused on optimizing the production of Ethyl 4-Boc-2-homomorpholinecarboxylate to improve yield and purity. Advances in catalytic methods, such as the use of palladium-catalyzed reactions, have significantly streamlined its synthesis, reducing the need for hazardous reagents and minimizing environmental impact. These improvements are expected to facilitate broader adoption of this compound in both academic and industrial settings.

Looking ahead, the potential of Ethyl 4-Boc-2-homomorpholinecarboxylate in drug discovery remains vast. Ongoing research is exploring its utility in the development of next-generation antibiotics and antiviral agents, particularly in response to the growing threat of antimicrobial resistance. Furthermore, its compatibility with green chemistry principles positions it as a sustainable option for future pharmaceutical manufacturing.

In conclusion, Ethyl 4-Boc-2-homomorpholinecarboxylate (CAS: 1363166-21-5) continues to be a pivotal compound in the field of medicinal chemistry, with its applications expanding across various therapeutic areas. The latest research underscores its versatility, efficacy, and potential for innovation, making it a subject of enduring interest for researchers and industry professionals alike.

• 868689-63-8((2S)-4-[(tert-butoxy)carbonyl]morpholine-2-carboxylic acid)
• 884512-77-0((2R)-4-[(tert-butoxy)carbonyl]morpholine-2-carboxylic acid)
• 1141669-61-5(4-[(tert-butoxy)carbonyl]-1,4-oxazepane-2-carboxylic acid)
• 1269755-24-9(4-Tert-Butyl 2-Methyl 2-Methylmorpholine-2,4-Dicarboxylate)
• 1273567-44-4((2S)-4-[(tert-butoxy)carbonyl]-1,4-oxazepane-2-carboxylic acid)
• 1416445-02-7((2R)-4-[(tert-butoxy)carbonyl]-6,6-dimethylmorpholine-2-carboxylic acid)
• 189321-66-2(4-[(tert-butoxy)carbonyl]morpholine-2-carboxylic acid)
• 1416444-82-0((2S)-4-[(tert-butoxy)carbonyl]-6,6-dimethylmorpholine-2-carboxylic acid)
• 500789-41-3(4-Tert-Butyl 2-methyl morpholine-2,4-dicarboxylate)
• 768371-16-0(Ethyl 4-Boc-2-morpholinecarboxylate)